Category: Regulatory

Introduction to Post Approval Change Post Approval Change (PAC) is defined as “any change to a product, process, or documents after approval by the relevant authorities.” The need for PAC is generally high in industries such as pharmaceuticals, biotechnology, and medical devices, where compliance is the key, even after the product is launched in the… Continue reading What Is Post Approval Change?

Introduction to Regulatory Variations Regulatory variations refer to differences in laws, rules, standards, and compliance requirements in different countries, regions, or industries. This affects how different companies operate, especially those expanding and growing globally.

Introduction to Marketing Authorization Marketing Authorization (MA) refers to a formal approval given by relevant authorities to a company to enable them to lawfully market and sell a given product within a particular country or geographical location.

What Is Drug Registration? Drug registration is defined as an official recognition of a pharmaceutical product by regulatory authorities before it is legally available for marketing and distribution in a given country. This ensures that a given drug meets set standards for safety, quality, and efficacy for public consumption.

What Is Drug Regulatory Approval? Drug regulatory approval is the formal process through which a pharmaceutical product is evaluated and authorized by regulatory authorities before it can be marketed and sold to the public.

What Is Global Regulatory Strategy? Global regulatory strategy is a methodical approach that is created by pharmaceutical firms in order to acquire and sustain regulatory acceptance of their products in various nations.

What Is Pharmaceutical Regulatory Compliance? Pharmaceutical regulatory compliance is the procedure through which pharmaceutical companies adhere to the set regulations, guidelines, and industry standards in order to guarantee the safety, quality, and efficacy of medicines.

What is an IND Application (Investigational New Drug Application) In the pharmaceutical industry, new drugs must undergo rigorous evaluation before they can be tested in humans. One of the most important regulatory steps in this process is the Investigational New Drug Application (IND). The IND allows pharmaceutical companies to begin clinical trials and ensures that… Continue reading What is an IND Application (Investigational New Drug Application)

Responding to FDA Form 483 Observations After a Drug CGMP Inspection Regulatory checks are very essential in the aspect of making sure that pharmaceutical producers are adhering to the existing requirements of Good Manufacturing Practice (CGMP). In an inspection, U.S. Food and drug administration (FDA) might find conditions that may be against regulatory provisions. Such… Continue reading How to Respond to FDA Form 483 Observations After a Drug CGMP Inspection

Understanding the FDA Draft Guidance on Biosimilar Development and the BPCI Act (Revision 4) The U.S. Food and Drug Administration (FDA) released New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 4) in March 2026 to clarify regulatory expectations for biosimilar and interchangeable biological products.